2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia: A Report of the American College of Cardiology Solution Set Oversight Committee

J Am Coll Cardiol. 2021 Aug 31;78(9):960-993. doi: 10.1016/j.jacc.2021.06.011. Epub 2021 Jul 28.
No abstract available

Keywords: ACC Expert Consensus Decision Pathway; atherosclerosis; docosahexaenoic acid; eicosapentaenoic acid; fatty acids omega-3; hypertriglyceridemia; lifestyle risk reduction; statins; triglycerides.

Publication types

  • Practice Guideline

MeSH terms

  • Cardiology* / methods
  • Cardiology* / trends
  • Cardiometabolic Risk Factors
  • Clinical Decision Rules
  • Consensus
  • Coronary Artery Disease* / prevention & control
  • Coronary Artery Disease* / therapy
  • Diet Therapy / methods*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Hypertriglyceridemia* / etiology
  • Hypertriglyceridemia* / metabolism
  • Hypertriglyceridemia* / psychology
  • Hypertriglyceridemia* / therapy
  • Nutrition Policy*
  • Patient Care Management / standards
  • Risk Assessment / methods
  • Risk Reduction Behavior*
  • United States

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors